|
Demicheva T.P.
Analysis of the quality of clinical follow-up care of patients with type 2 diabetes mellitus
|
№2 / 2024
|
|
Davidenko I.Yu., Volkova N.I., Degtyareva Yu.S.
Treatment options for different subtypes of gestational diabetes
|
№2 / 2024
|
|
Elsukova O.S., Nikitina E.A., Chuprova A.V., Kaysina O.A.
Possibilities of using a fixed combination of alogliptin and pioglitazone in patients with type 2 diabetes mellitus in everyday clinical practice
|
№2 / 2024
|
|
Suprun O.E., Bagriy A.E., Mikhailichenko E.S., Andreeva E.A., Evtushenko A.A., Suprun E.V.
Cohort study of clinical and anamnestic characteristics of patients with a combination of type 2 diabetes mellitus and irritable bowel syndrome
|
№2 / 2024
|
|
Demidova I.Yu., Boeva V.V.
Screening, diagnosis and treatment of early carbohydrate metabolism disorders
|
№2 / 2024
|
|
Antsiferov M.B., Antsiferova D.M., Koteshkova O.M., Demidov N.A.
The use of dulaglutide in real clinical practice in patients with type 2 diabetes mellitus in Moscow
|
№2 / 2024
|
|
Pavlova M.G.
Vildagliptin – 15 years in active service with diabetologists
|
№2 / 2024
|
|
Belova K.Yu., Ershova O.B., Nazarova A.V., Matyakubova Z.A.
Reasons and ways to reduce the severity of the acute phase reaction in the treatment of osteoporosis with intravenous bisphosphonates (literature review)
|
№2 / 2024
|
|
Leonova M.V.
Metformin prevents the development of atrial fibrillation
|
№2 / 2024
|
|
Rebrova D.V., Vorokhobina N.V.
Pegvisomant in the treatment of acromegaly
|
№2 / 2024
|
|
Zhurtova I.B., Aramisova L.S., Abdul Moati H.A., Arkhestova D.R., Khachmakhova E.Z.
Comparative characteristics of the incidence of various endocrinopathies in cancer patients receiving treatment with immune checkpoint inhibitors
|
№2 / 2024
|
|
Koteshkova O.M., Antsiferov M.B., Antsiferova D.M., Demidov N.A.
Modern technologies in diabetes management
|
№2 / 2024
|
Русский
